Ocumension Therapeutics (FRA:5DG)
0.8050
+0.0150 (1.90%)
At close: Jan 2, 2026
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of €716.7 million as of January 9, 2026. Its market cap has increased by 52.20% in one year.
Market Cap
716.70M
Enterprise Value
656.87M
Revenue
64.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.81
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 2.43B to 716.70M, a decrease of -70.47%. That is a compound annual growth rate of -19.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 716.70M | 8.55% |
| Dec 31, 2025 | 660.25M | 44.66% |
| Dec 31, 2024 | 456.43M | -14.58% |
| Dec 29, 2023 | 534.31M | -32.64% |
| Dec 30, 2022 | 793.26M | -39.71% |
| Dec 31, 2021 | 1.32B | -21.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |